Sotera Health (NASDAQ:SHC) Now Covered by Analysts at BMO Capital Markets

Analysts at BMO Capital Markets started coverage on shares of Sotera Health (NASDAQ:SHC) in a research note issued to investors on Thursday, Marketbeat reports. The brokerage set an “outperform” rating and a $19.00 price target on the stock. BMO Capital Markets’ price target points to a potential upside of 17.04% from the company’s current price.

Several other research firms have also commented on SHC. JPMorgan Chase & Co. boosted their price objective on shares of Sotera Health from $14.00 to $16.00 and gave the stock a “neutral” rating in a research report on Wednesday, November 5th. Weiss Ratings restated a “sell (d+)” rating on shares of Sotera Health in a research report on Friday, October 31st. Piper Sandler increased their price target on shares of Sotera Health from $15.00 to $17.00 and gave the company a “neutral” rating in a research report on Wednesday, November 5th. Barclays lifted their price objective on Sotera Health from $19.00 to $20.00 and gave the stock an “overweight” rating in a research report on Wednesday, November 5th. Finally, Wall Street Zen raised Sotera Health from a “buy” rating to a “strong-buy” rating in a research note on Saturday, August 16th. Four research analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat.com, Sotera Health currently has a consensus rating of “Hold” and a consensus price target of $17.67.

Sotera Health Stock Performance

NASDAQ SHC traded down $0.02 on Thursday, hitting $16.23. 576,178 shares of the company’s stock were exchanged, compared to its average volume of 1,498,923. The firm has a market cap of $4.61 billion, a price-to-earnings ratio of 85.45 and a beta of 1.82. The firm’s 50-day moving average price is $16.10 and its two-hundred day moving average price is $13.89. Sotera Health has a fifty-two week low of $9.53 and a fifty-two week high of $17.78. The company has a debt-to-equity ratio of 4.04, a current ratio of 2.38 and a quick ratio of 2.18.

Insider Activity at Sotera Health

In other Sotera Health news, Director Pincus & Co. Warburg sold 12,000,000 shares of the business’s stock in a transaction dated Friday, September 5th. The stock was sold at an average price of $15.11, for a total transaction of $181,320,000.00. Following the completion of the sale, the director owned 61,822,952 shares of the company’s stock, valued at approximately $934,144,804.72. The trade was a 16.26% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Gtcr Investment Xi Llc sold 12,000,000 shares of the firm’s stock in a transaction dated Monday, November 10th. The stock was sold at an average price of $15.65, for a total value of $187,800,000.00. Following the completion of the transaction, the director owned 29,215,301 shares in the company, valued at approximately $457,219,460.65. This trade represents a 29.12% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Over the last 90 days, insiders have sold 32,126,611 shares of company stock worth $492,073,888. 47.55% of the stock is owned by insiders.

Institutional Investors Weigh In On Sotera Health

Several institutional investors have recently bought and sold shares of the business. TPG GP A LLC acquired a new position in shares of Sotera Health during the first quarter worth about $79,126,000. Sculptor Capital LP raised its holdings in shares of Sotera Health by 80.8% during the 1st quarter. Sculptor Capital LP now owns 9,037,511 shares of the company’s stock valued at $105,377,000 after buying an additional 4,037,511 shares during the period. Vanguard Group Inc. lifted its position in Sotera Health by 10.5% during the 3rd quarter. Vanguard Group Inc. now owns 16,471,792 shares of the company’s stock worth $259,101,000 after acquiring an additional 1,561,282 shares in the last quarter. Norges Bank acquired a new stake in Sotera Health in the second quarter valued at approximately $9,607,000. Finally, Two Seas Capital LP raised its stake in shares of Sotera Health by 21.1% during the second quarter. Two Seas Capital LP now owns 4,020,867 shares of the company’s stock valued at $44,712,000 after purchasing an additional 699,731 shares during the period. 91.03% of the stock is currently owned by hedge funds and other institutional investors.

Sotera Health Company Profile

Sotera Health Company engages in the provision of sterilization, lab testing, and advisory services in the United States and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. It provides mission-critical end-to-end sterilization services, including gamma and electron beam irradiation, and ethylene oxide processing, as well as designs, installs, and maintains gamma irradiation systems.